WRT1V:OMXHEXWartsila Oyj Abp Analysis
Data as of 2026-07-16 - not real-time
€30.05
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading at €30.05, notably below its 20‑day SMA of €31.86 and the 200‑day SMA of €31.80, signaling short‑term weakness. The RSI sits at 36.7, hinting at a mildly oversold condition, while the MACD remains bearish with the line under the signal. Volume has been decreasing, and 30‑day volatility is high at 35.8%, suggesting price swings may continue in the near term.
Fundamental backdrop: Despite a modest revenue dip of 0.3%, Wärtsilä delivers a solid gross margin of 46.9% and a ROE of 27%, underscoring strong profitability. The balance sheet is robust with €2.12 bn cash versus €0.55 bn debt, and free cash flow exceeds €1.1 bn. Valuation is roughly in line with peers – a PE of 27.3 versus the industry average of 30.9 – while the DCF target of €27.6 suggests the current price is slightly premium. The dividend yield of 1.78% and a payout ratio under 45% indicate a sustainable income stream.
Fundamental backdrop: Despite a modest revenue dip of 0.3%, Wärtsilä delivers a solid gross margin of 46.9% and a ROE of 27%, underscoring strong profitability. The balance sheet is robust with €2.12 bn cash versus €0.55 bn debt, and free cash flow exceeds €1.1 bn. Valuation is roughly in line with peers – a PE of 27.3 versus the industry average of 30.9 – while the DCF target of €27.6 suggests the current price is slightly premium. The dividend yield of 1.78% and a payout ratio under 45% indicate a sustainable income stream.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below 20‑day SMA
- bearish MACD histogram
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong ROE and free cash flow generation
- valuation near industry average
- sustainable dividend yield
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- exposure to decarbonisation and energy transition markets
- robust balance sheet with low leverage
- stable dividend policy and attractive earnings yield
Key Metrics & Analysis
Financial Health
Revenue Growth-0.30%
Profit Margin9.40%
P/E Ratio27.3
ROE27.26%
ROA6.32%
Debt/Equity22.80
P/B Ratio7.4
Op. Cash Flow€1.4B
Free Cash Flow€1.1B
Industry P/E30.9
Technical Analysis
TrendNeutral
RSI36.7
Support€29.54
Resistance€34.55
MA 20€31.86
MA 50€33.70
MA 200€31.80
MACDBearish
VolumeDecreasing
Fear & Greed Index93.45
Valuation
Fair Value€27.58
Target Price€33.10
Upside/Downside10.15%
GradeFair
TypeBlend
Dividend Yield1.78%
Risk Assessment
Beta0.64
Volatility35.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.